statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Stock Radar: Aurobindo, Adani Ports, RVNL, NTPC, Torrent Pharma, Divis Labs, Glenmark in focus on Monday

More than 300 companies will release their quarterly earnings on May 27 including Life Insurance Corporation of India, Astrazeneca Pharma, Borosil Renewables, Flair Writing Industries, Jubilant Industries, Natco Pharma, and NALCO.

Glenmark Pharma Q4 net loss widens to Rs 1,239 crore

Glenmark Q4: Revenue rose two percent from the previous year to Rs 3,063 crore, from Rs 3,000.5 crore in the same period a year ago

Glenmark Pharma shares gain on US FDA nod for acetaminophen, ibuprofen tablets

Glenmark Pharmaceuticals Share Price | The share touched a 52-week high of Rs 1,095.95 and a 52-week low of Rs 516.65 on 25 April, 2024 and 26 April, 2023, respectively.

Lupin, Glenmark recall drugs in US market: USFDA

As per the latest Enforcement Report by the US Food and Drug Administration (USFDA), Lupin is recalling 26,352 bottles of Rifampin Capsules (300 mg), an antibiotic medication in the US market.

Lupin, Glenmark, Natco recall products from US markets

Lupin recalled 26,352 bottles of Rifampin capsules, used in the treatment of tuberculosis

Buy Glenmark Pharmaceuticals; target of Rs 1266: KR Choksey

KR Choksey is bullish on Glenmark Pharmaceuticals has recommended buy rating on the stock with a target price of Rs 1266 in its research report dated April 05, 2024.

Mantra by derivative lead analyst: Work religiously irrespective of temporary failures, have risk management systems in place

Being passionate about derivative after a decade of struggle, Shilpa Rout, Derivative Lead Analyst and AVP – Research at Prabhudas Lilladher, suggests taking Bull Call spread on Nifty monthly expiry with buying 22,500 CE buy and selling 23,100 CE.

Accumulate Glenmark Pharmaceuticals; target of Rs 984: KR Choksey

KR Choksey recommended Accumulate rating on Glenmark Pharmaceuticals with a target price of Rs 984 in its research report dated February 22, 2024.

Trade Spotlight | How you should deal in Gujarat Ambuja Exports, Craftsman Automation, Glenmark Pharma today

Glenmark Pharma formed bullish candlestick pattern on the daily scale with above average volumes. The stock showed nice recovery in last four days after falling closer to 200-day EMA, and now traded above all key moving averages.

Glenmark launches antidiabetic drug in India

The drug is being marketed under the brand name Lirafit following the approval from the Drug Controller General of India (DCGI), the company said in a statement.

Glenmark Pharmaceuticals Ltd. is a holding company, which engages in the development, manufacture, and marketing of pharmaceutical products. It operates through the India, North America, Latin America, Europe, and Rest of the World geographical segments. The company was founded by Gracias Saldanha on November 18, 1977 and is headquartered in Mumbai, India.

Volume	703,609.00
52-Wk High	1,451.00
52-Wk Low	722.10

GLENMARK.NSE Glenmark Pharmaceuticals Ltd.

About

Feed

News

Sentiment

Fundamentals